Five-year Outcome of Peripherally Inserted Central Catheters in Adults: a Separated Infectious and Thrombotic Complications Analysis
Overview
Infectious Diseases
Nursing
Public Health
Authors
Affiliations
Objective: To assess infectious and thrombotic complications of peripherally inserted central catheters (PICCs) in adults.
Design: A 5-year prospective cohort study.
Setting: Tertiary-care teaching hospital in Seville, Spain.
Patients: Adult patients undergoing PICC insertion.
Methods: Catheter-associated bloodstream infection (CABSI) including catheter-related bloodstream infection (CRBSI), primary bacteremia (PB), and upper extremity deep vein thrombosis (UEDVT) were recorded. Independent predictors of complications were assessed by multivariate analysis.
Results: In total, 1,142 PICCs were inserted, with 153,191 catheter days (median, 79). Complications included 66 cases of CABSI (5.78%; 0.43‰ catheter days), 38 cases of CRBSI (3.33%; 0.25‰ catheter days), 28 cases of PB (2.45%; 0.18‰ catheter days), and 23 cases of UEDVT (2.01%; 0.15‰ catheter days). The median times to infection were 24, 41, and 60 days for CRBSI, PB, and UEDVT, respectively. Parenteral nutrition (odds ratio [OR], 3.40; 95% confidence interval [CI], 1.77-6.52) and admission to the hematology ward (OR, 4.90; 95% CI, 2.25-10.71) were independently associated with CRBSI and PB, respectively. Admission to the hematology ward (OR, 12.46; 95% CI, 2.49-62.50) or to the oncology ward (OR, 7.89; 95% CI, 1.77-35.16) was independently associated with UEDVT. The crude mortality rate was 24.8%. Only 2 patients died of complications.
Conclusions: PICCs showed a low rate of thrombotic and infectious complications. Compared to PB, CRBSI showed significantly different risk factors, a higher incidence density per catheter days, and a shorter median time to infection. Separate analyses of CRBSI and PB are more specific and clinically useful when analyzing infectious complications.
Performance and safety of PowerPICC catheters and accessories: a prospective observational study.
Troubil M, Capozzoli G, Mussa B, Hodne M, Hoerauf K, Alsbrooks K BMJ Open. 2024; 14(9):e081288.
PMID: 39349374 PMC: 11448161. DOI: 10.1136/bmjopen-2023-081288.
Dos Santos B, Gomes Beato B, Ferreira E, Braga F, Reis P, Silveira R Support Care Cancer. 2024; 32(7):462.
PMID: 38922487 DOI: 10.1007/s00520-024-08636-7.
Curtis K, Gough K, Krishnasamy M, Tarasenko E, Hill G, Keogh S BMC Cancer. 2024; 24(1):498.
PMID: 38641574 PMC: 11027380. DOI: 10.1186/s12885-024-12099-8.
Rosich-Soteras A, Bonilla-Serrano C, Llaurado-Gonzalez M, Fernandez-Bombin A, Trivino-Lopez J, Barcelo-Querol L J Vasc Access. 2024; 26(2):432-440.
PMID: 38205609 PMC: 11894895. DOI: 10.1177/11297298231220537.
Sharp R, Xu Q, Pumpa R, Elliott L, Corsini N, Marker J BMC Nurs. 2024; 23(1):4.
PMID: 38163877 PMC: 10759691. DOI: 10.1186/s12912-023-01614-0.